Approval · Notice of Compliance 3859 · 1997
BAYGAM: Notice of Compliance 3859
Issued January 23, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3859
- Date
- January 23, 1997
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAYGAM | 02230579 | Cancelled Post Market |
Medicinal ingredients
- IMMUNOGLOBULIN (HUMAN) 18 PER per ML